MKP1 mediates resistance to therapy in HER2-positive breast tumors

Demet Candas; Jian-Jian Li

doi:10.1080/23723556.2014.997518

MKP1 mediates resistance to therapy in HER2-positive breast tumors

Demet Candas, Jian-Jian Li

Radiation Oncology

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Mitogen-activated protein kinase phosphatase 1 (MKP1 or DUSP1) is an antiapoptotic phosphatase that is overexpressed in many cancers, including breast cancer. MKP1 expression is inducible in radiation-treated breast cancer cells, and correlates with human epidermal growth factor receptor 2 (ERBB2, HER2) expression. The role of MKP1 in therapy resistance suggests that targeting MKP1 in HER2-positive breast tumors may significantly enhance the efficacy of anti-HER2 and other anticancer therapies.

Original language	English (US)
Article number	e997518
Journal	Molecular and Cellular Oncology
Volume	2
Issue number	4
DOIs	https://doi.org/10.1080/23723556.2014.997518
State	Published - Oct 2 2015

Keywords

breast cancer
HER2
mitochondria
MKP1
radioresistance

ASJC Scopus subject areas

Cancer Research
Molecular Medicine

Access to Document

10.1080/23723556.2014.997518

Fingerprint Dive into the research topics of 'MKP1 mediates resistance to therapy in HER2-positive breast tumors'. Together they form a unique fingerprint.

Cite this

@article{054532a7dc754cca89bf10a06f48be52,

title = "MKP1 mediates resistance to therapy in HER2-positive breast tumors",

abstract = "Mitogen-activated protein kinase phosphatase 1 (MKP1 or DUSP1) is an antiapoptotic phosphatase that is overexpressed in many cancers, including breast cancer. MKP1 expression is inducible in radiation-treated breast cancer cells, and correlates with human epidermal growth factor receptor 2 (ERBB2, HER2) expression. The role of MKP1 in therapy resistance suggests that targeting MKP1 in HER2-positive breast tumors may significantly enhance the efficacy of anti-HER2 and other anticancer therapies.",

keywords = "breast cancer, HER2, mitochondria, MKP1, radioresistance",

author = "Demet Candas and Jian-Jian Li",

year = "2015",

month = oct,

day = "2",

doi = "10.1080/23723556.2014.997518",

language = "English (US)",

volume = "2",

journal = "Molecular and Cellular Oncology",

issn = "2372-3556",

publisher = "Taylor and Francis Ltd.",

number = "4",

}

TY - JOUR

T1 - MKP1 mediates resistance to therapy in HER2-positive breast tumors

AU - Candas, Demet

AU - Li, Jian-Jian

PY - 2015/10/2

Y1 - 2015/10/2

N2 - Mitogen-activated protein kinase phosphatase 1 (MKP1 or DUSP1) is an antiapoptotic phosphatase that is overexpressed in many cancers, including breast cancer. MKP1 expression is inducible in radiation-treated breast cancer cells, and correlates with human epidermal growth factor receptor 2 (ERBB2, HER2) expression. The role of MKP1 in therapy resistance suggests that targeting MKP1 in HER2-positive breast tumors may significantly enhance the efficacy of anti-HER2 and other anticancer therapies.

AB - Mitogen-activated protein kinase phosphatase 1 (MKP1 or DUSP1) is an antiapoptotic phosphatase that is overexpressed in many cancers, including breast cancer. MKP1 expression is inducible in radiation-treated breast cancer cells, and correlates with human epidermal growth factor receptor 2 (ERBB2, HER2) expression. The role of MKP1 in therapy resistance suggests that targeting MKP1 in HER2-positive breast tumors may significantly enhance the efficacy of anti-HER2 and other anticancer therapies.

KW - breast cancer

KW - HER2

KW - mitochondria

KW - MKP1

KW - radioresistance

UR - http://www.scopus.com/inward/record.url?scp=85034048660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034048660&partnerID=8YFLogxK

U2 - 10.1080/23723556.2014.997518

DO - 10.1080/23723556.2014.997518

M3 - Article

AN - SCOPUS:85034048660

VL - 2

JO - Molecular and Cellular Oncology

JF - Molecular and Cellular Oncology

SN - 2372-3556

IS - 4

M1 - e997518

ER -